Tiago Fauth
Stock Analyst at Wells Fargo
(0)
# 4768
Out of 5,240 analysts
151
Total ratings
25.74%
Success rate
-23.22%
Average return
Main Sectors:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Inozyme Pharma | Maintains: Overweight | 14 11 | 1.5 | 633.33% | 2 | Jan 13, 2025 | |
Verona Pharma | Maintains: Overweight | 64 74 | 48.69 | 51.98% | 3 | Jan 8, 2025 | |
Ultragenyx Pharmaceu... | Maintains: Overweight | 75 88 | 42.46 | 107.25% | 7 | Dec 20, 2024 | |
Savara | Initiates Coverage On: Overweight | 8 | 2.8 | 185.71% | 1 | Dec 20, 2024 | |
MannKind | Initiates Coverage On: Overweight | 9 | 6.09 | 47.78% | 1 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 88 111 | 10.42 | 965.26% | 2 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 56 68 | 43.22 | 57.33% | 1 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 55 79 | 39.28 | 101.12% | 2 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 11 22 | 11.82 | 86.13% | 2 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 75 | 59.34 | 26.39% | 1 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 350 380 | 369.99 | 2.71% | 4 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 207 233 | 250.03 | -6.81% | 4 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 35 2 | 2.46 | -18.7% | 2 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 55 77 | 69.9 | 10.16% | 2 | May 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 63 62 | 1.97 | 3047.21% | 5 | Aug 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Neutral | 89 | 135 | -34.07% | 16 | Jun 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Outperform | 51 | 16.97 | 200.53% | 3 | Jun 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Outperform | 120 | 63.73 | 88.29% | 7 | Jun 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 120 | 3.48 | 3348.28% | 6 | May 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Underperform | 4 | 23.74 | -83.15% | 4 | May 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 22 17 | n/a | n/a | 2 | May 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 14 | 2.81 | 398.22% | 4 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 4 | 0.36 | 1011.11% | 5 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 26 | 7.42 | 250.4% | 5 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 34 28 | 2.97 | 842.76% | 7 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 70 81 | 29.71 | 172.64% | 11 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 139 200 | n/a | n/a | 5 | Apr 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Underperform | 1 | n/a | n/a | 3 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 8 | 0.5 | 1500% | 5 | Mar 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 14 | 1.41 | 892.91% | 2 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 38 34 | 1.61 | 2011.8% | 2 | Mar 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 150 | 4.85 | 2992.78% | 2 | Mar 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 29 | 36.33 | -20.18% | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 13 | 3.32 | 291.57% | 1 | Dec 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 25 13 | 1.23 | 956.91% | 2 | Nov 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 20 | n/a | n/a | 3 | Sep 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underperform | 3 2 | 2.42 | -17.36% | 4 | May 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 297 340 | 661.93 | -48.64% | 3 | Dec 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 15 18 | n/a | n/a | 2 | Sep 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 102 98 | n/a | n/a | 1 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 265 259 | 270.74 | -4.34% | 1 | Apr 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 60 42 | n/a | n/a | 5 | Nov 10, 2020 |